“Clinical trials led by researchers with characteristic as donation have risks to violate Kim Young-Ran Law”

An argument was suggested that there is a chance for clinical trials led by researchers with the characteristics of donation to violate the Bribery Prohibition Law.

The Transparent Pharmaceutical Business Network held its inauguration ceremony and a briefing session about the ‘Anti-Corruption and Bribery Prohibition Law(Kim Young-Ran Law)’ which has been enforced from the 28^th and the ‘Complia...